![[Ala2,8,9,11,19,22,24,25,27,28]-VIP](https://file.medchemexpress.com/product_pic/hy-p1158.gif "Click to View [Ala2,8,9,11,19,22,24,25,27,28]-VIP Product Detail")
Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
12 Results for "
Pituitary Adenylate Cyclase-Activating Polypeptide
" in MedChemExpress (MCE) Product Catalog:
Products (12)
12 Results for "Pituitary Adenylate Cyclase-Activating Polypeptide" in MCE Product Catalog:
5
5 Cited Publications
Cat. No.: HY-P0221
CAS No.: 137061-48-4
Synonyms: Pituitary Adenylate Cyclase Activating Polypeptide 38
Research Areas:
1
1 Cited Publications
Synonyms: PAC1R antagonist 1
Target:
Research Areas:
PA-915 (PAC1R antagonist 1) is a potent and orally active antagonist of PAC1 receptor. PA-915 inhibits pituitary adenylate cyclase-activating polypeptide (PACAP)-induced CREB phosphorylation. PA-915 can inhibit PACAP- and nerve injury-induced allodynia. PA-915 can be used for the research of neuropathic pain .
Target:
Research Areas:
PA-9 is a pituitary adenylate cyclase-activating polypeptide (PACAP) type I (PAC1) receptor antagonist. PA-9 dose dependently inhibits PACAP-induced cAMP elevation with an IC50 of 5.6 nM. PA-9 can be used for the research of neuropathic and/or inflammatory pain .
Cat. No.: HY-P1158
CAS No.: 866552-34-3
Target:
Research Areas:
Cat. No.: HY-P0221A
Synonyms: Pituitary Adenylate Cyclase Activating Polypeptide 38 TFA
Research Areas:
Cat. No.: HY-P77120A
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: ADCYAP1R1; PAC1 Receptor; ADCYAP Receptor Type I; PACAP-R1; PAC1R; Pituitary Adenylate Cyclase Activating Polypeptide 1 Receptor Type I Hiphop Splice Variant; Pituitary Adenylate Cyclase-Activating Polypeptide Type I Receptor; Pituitary Adenylate Cyclase
Species:
Human
Source:
HEK293
Cat. No.: HY-P77120
Purity: ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: ADCYAP1R1; PAC1 Receptor; ADCYAP Receptor Type I; PACAP-R1; PAC1R; Pituitary Adenylate Cyclase Activating Polypeptide 1 Receptor Type I Hiphop Splice Variant; Pituitary Adenylate Cyclase-Activating Polypeptide Type I Receptor; Pituitary Adenylate Cyclase
Species:
Human
Source:
HEK293
Cat. No.: HY-P81526
Synonyms: VIP2R; VIPR2; Vasoactive intestinal Polypeptide receptor 2; VIP-R-2; Helodermin-preferring VIP receptor; Pituitary Adenylate Cyclase-Activating Polypeptide type III receptor (PACAP type III receptor; PACAP-R-3; PACAP-R3); VPAC2
Cat. No.: HY-P81526A
Synonyms: VIP2R; VIPR2; Vasoactive intestinal Polypeptide receptor 2; VIP-R-2; Helodermin-preferring VIP receptor; Pituitary Adenylate Cyclase-Activating Polypeptide type III receptor (PACAP type III receptor; PACAP-R-3; PACAP-R3); VPAC2
Cat. No.: HY-P76128
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: VIPR2; Vasoactive Intestinal Peptide Receptor 2; VPAC2R; Pituitary Adenylate Cyclase-Activating Polypeptide Type III Receptor; Vasoactive Intestinal Polypeptide Receptor 2; VPAC2; Helodermin-Preferring VIP Receptor; VIP And PACAP Receptor 2; PACAP Type II
Species:
Human
Source:
HEK293
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
